Enliven Therapeutics shares owned by Barclays
Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Barclays
from 13F filings
Historical chart of Barclays investment in Enliven Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Enliven Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enliven Therapeutics by Barclays
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.4M | 71k | 20.47 |
| 2025-06-30 | $1.5M | 73k | 20.05 |
| 2025-03-31 | $991k | 50k | 19.68 |
| 2024-12-31 | $1.5M | 65k | 22.51 |
| 2024-09-30 | $1.4M | 56k | 25.53 |
| 2024-06-30 | $331k | 14k | 23.30 |
| 2024-03-31 | $462k | 26k | 17.61 |
| 2023-12-31 | $583k | 42k | 13.85 |
| 2023-09-30 | $186k | 14k | 13.65 |
| 2023-06-30 | $303k | 15k | 20.44 |
| 2023-03-31 | $158k | 7.2k | 21.86 |